aamc.org does not support this web browser.

Advocacy & Policy

Advocacy & Policy

Two-page fact sheet detailing how J-1 and H-1B visa holders serve as an important complement within the health workforce, helping to fill gaps in the shortage.

  • PDF
Clinical Care

The AAMC and its member organizations have an important partnership with the VA to ensure veterans receive the care they deserve.

Advocacy & Policy

A resource outlining Trump administration executive actions most likely to impact academic medicine.

About Our Advocacy

The AAMC works with policymakers and other leaders to advance policy priorities that strengthen the nation’s health and well-being.

Learn more about how the AAMC advocates on behalf of academic medicine.

Learn About Our Advocacy

Our Legislative and Policy Priorities

People with raised fists at a demonstration in the city

AAMC Action – Let’s Raise Our Voices Together

AAMC Action is a community of students, residents, researchers, faculty members, physicians, and others who advocate on behalf of academic medicine to improve the health of people everywhere.

Join Us

Find Advocacy & Policy Content

  • Recent
  • Relevance
2101 - 2105 of 3761 results No filters applied
Washington Highlights

The AAMC submitted a joint letter to the White House Office of Science and Technology Policy on implementing NSPM-33, a presidential memo on research security.

  • Oct. 15, 2021
Testimony & Correspondence

The AAMC submitted comments on Oct. 15 to a U.S. Patent and Trademark Office request for public input in its study of recent jurisprudence regarding patentabili

  • Oct. 15, 2021
  • PDF
Testimony & Correspondence

AAMC Comments on Enforcement on No Surprises Act

  • Oct. 14, 2021
  • PDF
Testimony & Correspondence

Comment Letter in Support of Repeal of MCIT and Change in Definition of “Reasonable and Necessary”

  • Oct. 12, 2021
  • PDF
Washington Highlights

NIH Director Francis Collins, MD, PhD, announced on Oct. 5 that he will step down from his role by the end of 2021.

  • Oct. 8, 2021
National Health Institute Director Francis S. Collins testifies at a Senate Labor, Health and Human Services, Education and Related Agencies Subcommittee hearing on manufacturing a Coronavirus vaccine on Capitol Hill on July 2, 2020 in Washington, DC.
Capitol building, Washington, DC

Washington Highlights

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting academic medicine.

Subscribe to receive weekly Hill and regulatory updates to your inbox.

Subscribe